BioMed Central | Articles which cite: Vaccination with EphA2-derived T cell-epitopes promotes immunity against both EphA2-expressing and EphA2-negative tumors.

home journals A-Z subject areas advanced search authors reviewers libraries about my BioMed Central

printer friendly

to [Help]

PubMed Central articles that cite the above article:

1.	EphA2 as a glioma-associated antigen: a novel target for glioma vaccines. Hatano M, Eguchi J, Tatsumi T, Kuwashima N, Dusak JE, Kinch MS, Pollack IF, Hamilton RL, Storkus WJ, Okada H Neoplasia 2005 Aug, 7:717-22 [PubMed Central] [PubMed] [Related articles]
2.	Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1. Ueda R, Kohanbash G, Sasaki K, Fujita M, Zhu X, Kastenhuber ER, McDonald HA, Potter DM, Hamilton RL, Lotze MT, Khan SA, Sobol RW, Okada H Proc Natl Acad Sci U S A 2009 Jun 30, 106:10746-51 [PubMed Central] [PubMed] [Related articles]
3.	Immunotherapeutic approaches for glioma. Okada H, Kohanbash G, Zhu X, Kastenhuber ER, Hoji A, Ueda R, Fujita M Crit Rev Immunol 2009, 29:1-42 [PubMed Central] [PubMed] [Related articles]

This article is also cited by 2 articles in BioMed Central

printer friendly

to [Help]